Skip to content

Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease

Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04163484
Enrollment
156
Registered
2019-11-14
Start date
2019-01-15
Completion date
2024-05-30
Last updated
2024-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Angina, Stable, Angina, Unstable, Contrast-induced Nephropathy, Coronary Artery Disease, NSTEMI - Non-ST Segment Elevation MI, STEMI - ST Elevation Myocardial Infarction

Keywords

coronary artery disease, iodinated contrast media, stable angina, unstable angina, STEMI, NSTEMI, PCI, acute kidney injury

Brief summary

The goal of the study is to assess the prevalence of contrast-associated acute kidney injury in patients with stable coronary artery disease, ST-elevation myocardial infarction and unstable angina/NSTEMI, assess the risk factors of contrast-induced acute kidney injury development and the influence of contrast-induced kidney injury on 1-year prognosis.

Interventions

OTHERIodinated contrast

Intra-arterial injection of iodinated contrast media during percutaneous coronary intervention

Sponsors

I.M. Sechenov First Moscow State Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

* Males and females aged 18-80 * Stable CAD receiving optimal medical treatment requiring PCI or STEMI or NSTEMI * Intra-arterial injection of iodinated contrast media * Informed consent

Exclusion criteria

* Age less than 18 * Pregnancy, lactation * Refuse to sign the informed consent * Contraindications for PCI * Other conditions affecting prognosis (oncology, liver failure etc) * CKD stage 4-5 * Patients receiving nephrotoxic drugs

Design outcomes

Primary

MeasureTime frameDescription
Contrast associated acute kidney injury48-72 hoursNumber of patients with contrast associated kidney injury after contrast exposure

Secondary

MeasureTime frameDescription
Overall mortality1 year
Cardiovascular mortality1 year
Myocardial infarction1 yearNumber of patients with myocardial infarction
Stroke1 year
Acute decompensation of heart failure1 yearNumber of patients with acute decompensation of heart failure
Repeat hospitalisation1 year
Chronic kidney disease progression1 yearProgression of chronic kidney disease in patients with decreased glomerular filtration rate on inclusion
New-onset dialysis1 yearNumber of patients with new-onset dialysis
Repeat revascularization1 yearPCI or CABG

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026